c="Chemical cleavage method" 1:0 1:2||t="test"||cui="C0201683"||tot="Chemical method"||ns="-913"
c="osteogenesis imperfecta" 1:18 1:19||t="problem"||cui="C0029434"||tot="Osteogenesis Imperfecta"||ns="-1000"
c="osteogenesis imperfecta (OI" 2:7 2:9||t="problem"||cui="C0029434"||tot="Osteogenesis Imperfecta"||ns="-1000"
c="hydroxylamine" 2:38 2:38||t="test"||cui="C0020362"||tot="Hydroxylamine"||ns="-1000"
c="osmium tetroxide" 2:43 2:44||t="test"||cui="C0029385"||tot="Osmium Tetroxide"||ns="-1000"
c="radioactively labeled DNA probes" 2:69 2:72||t="treatment"||cui="C0012893"||tot="DNA probe"||ns="-842"
c="perinatally lethal OI" 2:107 2:109||t="problem"||cui="C0268358"||tot="Osteogenesis imperfecta, perinatal lethal"||ns="-973"
c="OI type II" 2:110 2:112||t="problem"||cui="C0268358"||tot="Osteogenesis imperfecta, perinatal lethal"||ns="-1000"
